Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

Tempus AI surges 91.8% YTD with soaring genomics revenues and a $200M AstraZeneca deal, outpacing NVIDIA in AI healthcare gains.

Denmark's Export and Investment Fund (EIFO) and the Novo Nordisk Foundation (NNF) are set to invest €80 million ($92.93m) to ...

Baxdrostat is a highly selective, second-generation, nonimidazole aldosterone synthase inhibitor; 100 times less baxdrostat ...

Denmark is investing 80 million euro in a quantum computing project intended to bring a commercial-grade system to the Nordic ...

French MBE company Riber has reported its results for the first half of 2025 with revenues of €10.7m, down 22 percent ...

These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...

"While U.S. POINTER was designed and powered as a head-to-head comparison of the two interventions, and a statistically ...

For this, male and female hemizygous (AS) and homozygous (SS) Townes mice (4 months old) were fasted for 4 hours and 60 ...

A nationwide Danish study finds that the incidence of paediatric stroke is rising among boys while remaining stable among ...

A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...

Obesity increases the risk of nearly 200 diseases. A new genetic test may be able to predict a young child's risk of obesity ...